Healthy Inc > Blog > WHO-GMP FDC exporter Mumbai
Posted on:

What is paracetamol 500mg phenylephrine 5mg caffeine 30mg diphenhydramine 25mg?

In the pharmaceutical industry, this Quadruple Combination is an advanced “Night-Time Cold & Flu” formulation. As a pharmacist and manufacturer, I view this as a “Comprehensive Symptom Suppressor” that targets pain, congestion, and the inflammatory response, while providing a mild sedative effect to help patients rest during a viral infection.

At your WHO-GMP facility in Mumbai, this Fixed-Dose Combination (FDC) is a high-value SKU. It is technically more complex to stabilize than a single-ingredient tablet, making it a strong “technical authority” product for your B2B export portfolio.

Therapeutic Profile: The 4-Way Target

Each component in this 500/5/30/25 mg matrix has a specific pharmacological role:

ComponentClassPrimary Function
Paracetamol (500 mg)Analgesic/AntipyreticReduces fever and treats headaches/body aches.
Phenylephrine (5 mg)Nasal DecongestantShrinks swollen nasal tissues to clear a blocked nose.
Caffeine (30 mg)Central StimulantEnhances the pain-killing effect of Paracetamol and offsets excessive “brain fog.”
Diphenhydramine (25 mg)1st Gen AntihistamineStops runny nose/sneezing and provides a sedative effect for sleep.
Mechanism: Multi-Pathway Suppression

This combination works by simultaneously addressing the CNS and the peripheral inflammatory response:

Analgesic Synergy: Paracetamol inhibits prostaglandin synthesis in the brain. The Caffeine (30 mg) acts as an adjuvant, increasing the speed and depth of pain relief by up to 40%.

Adrenergic Decongestion: Phenylephrine stimulates -adrenergic receptors, causing vasoconstriction in the nasal mucosa. This reduces the “leakage” of fluid that causes congestion.

H1-Receptor Blockade: Diphenhydramine competes with histamine for H1-receptor sites. Because it is a 100% “first-generation” antihistamine, it crosses the blood-brain barrier easily, which is why it effectively causes the drowsiness needed for a patient to rest.

The Pharmacist’s “Technical Warning”

  • The “Rest” Mandate: As a pharmacist, I must emphasize that Diphenhydramine (25 mg) causes significant sedation. This formulation is strictly for “Night-Time” use. Patients must not drive or operate machinery.

  • The Hypertension Trap: Phenylephrine is a vasoconstrictor. It can raise blood pressure and is contraindicated in patients with uncontrolled hypertension or severe coronary artery disease.

  • The “Anticholinergic” Burden: Diphenhydramine can cause dry mouth, blurred vision, and urinary retention. Use with caution in elderly patients or those with an enlarged prostate.

  • The “Liver Ceiling”: Remind patients not to take other Paracetamol-containing products to avoid exceeding the 4,000 mg daily limit.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Single-Tablet Compliance” USP: On your digital marketplace, highlight that this single tablet replaces four separate medicines. This is a massive selling point for B2B buyers in the “OTC Convenience” and “Hospital Pharmacy” sectors.

  • Stability of the Matrix: Caffeine and Diphenhydramine can be hygroscopic. Utilizing Alu-Alu blister packaging is essential for preventing moisture ingress and ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for this 4-in-1 FDC to support your firm’s registration in international tenders for “Critical Cold & Flu Care.”

paracetamol caffeine phenylephrine cpm Tablets

Posted on:

Is paracetamol ibuprofen safe?

In the pharmaceutical industry, the combination of Paracetamol (Acetaminophen) and Ibuprofen is considered a gold standard for multi-modal analgesia. As a pharmacist and manufacturer, I view this pairing as a “Synergistic Force”: they are remarkably safe when used together at correct dosages because they process through different organs and use different biological pathways.

At your WHO-GMP facility in Mumbai, where you likely handle these as high-volume SKUs, emphasizing the safety and efficacy of this combination is a core technical value-add for your B2B pain management portfolio.

The Safety Profile: “Split Metabolism”

The primary reason this combination is considered safe is that it does not “overload” a single organ system:

DrugPrimary MetabolismTarget Site
ParacetamolLiver (Hepatic)Central Nervous System (Brain).
IbuprofenKidneys (Renal)Peripheral Tissues (Site of injury/inflammation).

By splitting the workload between the liver and kidneys, the body can handle both drugs simultaneously without the toxic accumulation that might occur if you doubled the dose of just one of them.

Clinical Advantages of the Combination

Lower Individual Doses: Because they work synergistically, you can often achieve superior pain relief using lower doses of each drug than you would need if using them individually.

Multi-Modal Relief: Ibuprofen addresses the inflammation and swelling at the source, while Paracetamol modulates the pain threshold in the brain.

Fever Control: Both are antipyretics, making the combination highly effective for high-grade fevers that don’t respond to monotherapy.

The Pharmacist’s “Technical Safety Checklist”

Even though they are safe together, there are strict technical boundaries that must be communicated to your B2B clients:

  • The 4-Gram Rule: The total daily dose of Paracetamol must never exceed 4,000 mg (4g). Exceeding this can lead to acute liver failure.

  • The Gastric Barrier: Ibuprofen is an NSAID and can irritate the stomach lining. It should always be taken with food or milk, even when combined with Paracetamol.

  • Hidden Ingredients: Many “Cold & Flu” or “Sinus” FDCs already contain Paracetamol. Advise patients to check all labels to avoid accidental doubling of the dose.

  • Chronic Conditions: Patients with existing liver disease (avoid Paracetamol) or kidney disease/peptic ulcers (avoid Ibuprofen) must consult a physician before using the combination.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility:

  • The “FDC” Opportunity: On your digital marketplace, highlight your Fixed-Dose Combination (FDC) tablets (e.g., 500mg Paracetamol + 200mg Ibuprofen). These are increasingly popular in international markets because they improve patient compliance.

  • Stability for Export: For export to Zone IVb tropical regions, utilize Alu-Alu or high-barrier PVC/PVDC blisters. Ibuprofen is heat-sensitive and can degrade if the packaging is insufficient for high-humidity environments.

  • Dossier Support: We provide full CTD/eCTD Dossiers for these combinations, which are essential for registering products in international pharmacy chain tenders.

Ibuprofen 200 mg with Paracetamol 325 mg Tablets

Add to cart